{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:03:34Z","timestamp":1794971014916,"version":"4.9.1"},"reference-count":80,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PNT"],"published-print":{"date-parts":[[2019,5,10]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Onychomycosis accounts for 50% of all nail disease cases and is commonly\ncaused by dermatophytes. It was primarily considered a cosmetic problem\nbut has been garnering attention lately due to its persistent nature and difficult\ntreatment with relapses. With prolonged treatment duration and high cost involved\nin treating onychomycosis, several attempts have been made in overcoming the\nrigid nail barrier. The conventional treatment of onychomycosis involves oral and\ntopical therapy. The oral antifungal agents though quite effective, are hepato-toxic\nand cause drug-drug interactions. Topical therapy is more patient compliant being\ndevoid of such adverse effects but it suffers from another setback of improper nail\npenetration. Amorolfine and ciclopirox nail lacquers are popular market products.\nSince decades, efforts have been made to enhance topical delivery for efficiently\ntreating onychomycosis. Mechanical, physical and chemical methods have been\nemployed. Despite all the attempts made, the nail delivery issues are far from being\nsolved. Recently, the focus has shifted to novel drug delivery systems like nanoparticles,\nmicroemulsions, polymeric films and nail lacquers for enhanced drug\npermeation and localized therapy. The research around the world is exploring their\npotential as effective treatment options. This review intends to further explore the\nnovel delivery strategies to treat a persistent fungal infection like onychomycosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2211738507666190228104031","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T02:58:27Z","timestamp":1557457107000},"page":"24-38","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Novel Drug Delivery Strategies for the Treatment of Onychomycosis"],"prefix":"10.2174","volume":"7","author":[{"given":"Rupinder K.","family":"Dhamoon","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, Sector-3, M.B Road, New Delhi -110017, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvinder","family":"Popli","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, Sector-3, M.B Road, New Delhi -110017, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, Sector-3, M.B Road, New Delhi -110017, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s12272-016-0774-0","volume":"39","author":"Thapa R.K.","year":"2016","unstructured":"Thapa RK, Choi JY, Go TG. Arch Pharm Res, Development of ciclopirox nail lacquer with enhanced permeation and retention.,, 2016, 39,, 953-959,","journal-title":"Arch Pharm Res"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejpb.2016.03.008","volume":"102","author":"McAuley W.J.","year":"2016","unstructured":"McAuley WJ, Jones SA, Traynor MJ, Guesn\u00e9 S, Murdan S, Brown MB. Eur J Pharm Biopharm, An investigation of how fungal infection influences drug penetration through onychomycosis patient\u2019s nail plates.,, 2016, 102,, 178-184,","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=3","first-page":"E20","volume":"95","author":"Adekhandi S.","year":"2015","unstructured":"Adekhandi S, Pal S, Sharma N, Juyal D. Cutis, Incidence and epidemiology of onychomycosis in patients visiting a tertiary care hospital in India.,, 2015, 95,, E20-E5,","journal-title":"Cutis"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"e1004105","DOI":"10.1371\/journal.ppat.1004105","volume":"10","author":"Ghannoum M.","year":"2014","unstructured":"Ghannoum M, Isham N. PLoS Pathog, Fungal nail infections [onychomycosis]: a never-ending story?,, 2014, 10,, e1004105-,","journal-title":"PLoS Pathog"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03639045.2015.982946","volume":"41","author":"Kushwaha A.","year":"2015","unstructured":"Kushwaha A, Murthy RN, Murthy SN, Elkeeb R, Hui X, Maibach HI. Drug Dev Ind Pharm, Emerging therapies for the treatment of ungual onychomycosis.,, 2015, 41,, 1-7,","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=6","first-page":"1","volume":"23","author":"Bseiso E.A.","year":"2015","unstructured":"Bseiso EA, Nasr M, Sammour OA, Abd El Gawad NA. Drug Deliv, Novel nail penetration enhancer containing vesicles \u201cnPEVs\u201d for treatment of onychomycosis.,, 2015, 23,, 1-7,","journal-title":"Drug Deliv"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijpharm.2017.08.115","volume":"531","author":"Rocha K.A.D.","year":"2017","unstructured":"Rocha KAD, Krawczyk-Santos AP, Andrade LM. Int J Pharm, Voriconazole-loaded nanostructured lipid carriers [NLC] for drug delivery in deeper regions of the nail plate.,, 2017, 531,, 292-298,","journal-title":"Int J Pharm"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1208\/s12249-017-0831-0","volume":"19","author":"Shah V.H.","year":"2018","unstructured":"Shah VH, Jobanputra A. AAPS PharmSciTech, Enhanced ungual permeation of terbinafine HCL delivered through liposome-loaded nail lacquer formulation optimized by QbD approach.,, 2018, 19,, 213-224,","journal-title":"AAPS PharmSciTech"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejps.2016.12.043","volume":"100","author":"Flores F.C.","year":"2017","unstructured":"Flores FC, Rosso RS, Cruz L, Beck RCR, Silva CB. Eur J Pharm Sci, An innovative polysaccharide nanobased nail formulation for improvement of onychomycosis treatment.,, 2017, 100,, 56-63,","journal-title":"Eur J Pharm Sci"},{"key":"ref=10","first-page":"71","volume":"20","author":"Turner R.","year":"2016","unstructured":"Turner R, Weaver S, Caserta F, Brown MB. AAPS PharmSciTech, The inadequacies of the current treatment plans give rise to the pressing need for a topical ungual treatment, allowing site specific delivery and minimizing systemic exposure.,, 2016, 20,, 71-80,","journal-title":"AAPS PharmSciTech"},{"key":"ref=11","first-page":"17151","volume":"2014","author":"Ferrari J.","year":"2014","unstructured":"Ferrari J. Clin Evid, Fungal toenail infections. BMJ.,, 2014, 2014,, 17151-,","journal-title":"Clin Evid"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0159661","volume":"11","author":"Matsuda Y.","year":"2016","unstructured":"Matsuda Y, Sugiura K, Hashimoto T, Ueda A, Konno Y, Tatsumi Y. PLoS One, Efficacy coefficients determined using nail permeability and antifungal activity in keratin-containing media are useful for predicting clinical efficacies of topical drugs for onychomycosis.,, 2016, 11,, 1-12,","journal-title":"PLoS One"},{"key":"ref=13","first-page":"762","volume":"25","author":"Westerberg D.P.","year":"2014","unstructured":"Westerberg DP, Voyack MJ. Am Fam Physician, Onychomycosis: current trends in diagnosis and treatment.,, 2014, 25,, 762-770,","journal-title":"Am Fam Physician"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/1061186X.2014.929138","volume":"2330","author":"Saner M.V.","year":"2014","unstructured":"Saner MV, Kulkarni AD, Pardeshi CV. J Drug Target, Insights into drug delivery across the nail plate barrier.,, 2014, 2330,, 769-789,","journal-title":"J Drug Target"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijpharm.2013.08.082","volume":"456","author":"Hafeez F.","year":"2013","unstructured":"Hafeez F, Hui X, Chiang A, Hornby S, Maibach H. Int J Pharm, Transungual delivery of ketoconazole using novel lacquer formulation.,, 2013, 456,, 357-361,","journal-title":"Int J Pharm"},{"key":"ref=16","first-page":"434","volume":"3","author":"Paula D.A.","year":"2015","unstructured":"Paula DA, Carbinatto FM, Bagnato VS, Inada NM. J Pharm Pharmacol, A promising strategy for the treatment of onychomycosis with curcumin and photodynamic therapy.,, 2015, 3,, 434-437,","journal-title":"J Pharm Pharmacol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1203475417716362","volume":"21","author":"Gupta A.K.","year":"2017","unstructured":"Gupta AK, Versteeg SG, Shear NH. J Cutan Med Surg, Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment.,, 2017, 21,, 525-539,","journal-title":"J Cutan Med Surg"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1387936","DOI":"10.1155\/2016\/1387936","volume":"2016","author":"Akhtar N.","year":"2016","unstructured":"Akhtar N, Sharma H, Pathak K. Scientifica, Onychomycosis: potential of nail lacquers in transungual delivery of antifungals.,, 2016, 2016,, 1387936-,","journal-title":"Scientifica"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0973-8398.41567","volume":"2","author":"Bhise K.","year":"2008","unstructured":"Bhise K, Jan S, Bora D. Asian J Pharm, Preungual drug delivery systems of terbinafine hydrochloride nail lacquer.,, 2008, 2,, 53-,","journal-title":"Asian J Pharm"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10354-012-0139-3","volume":"163","author":"Tchernev G.","year":"2013","unstructured":"Tchernev G, Penev PK, Nenoff P. Wien Med Wochenschr, Onychomycosis: Modern diagnostic and treatment approaches.,, 2013, 163,, 1-12,","journal-title":"Wien Med Wochenschr"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.clindermatol.2013.06.011","volume":"31","author":"Gupta A.K.","year":"2013","unstructured":"Gupta AK, Paquet M, Simpson FC. Clin Dermatol, Therapies for the treatment of onychomycosis.,, 2013, 31,, 544-554,","journal-title":"Clin Dermatol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0011-393X(02)80040-6","volume":"63","author":"Lecha M.","year":"2002","unstructured":"Lecha M, Alsina M, Rodriguez JMT. Curr Ther Res Clin Exp, An open-label, multicenter study of the combination of amorolfine nail lacquer and oral ltraconazole compared with oral ltraconazole alone in the treatment of severe toenail onychomycosis.,, 2002, 63,, 366-379,","journal-title":"Curr Ther Res Clin Exp"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2133.2007.07974.x","volume":"157","author":"Baran R.","year":"2007","unstructured":"Baran R, Sigurgeirsson B, Berker D De. Br J Dermatol, A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix in.,, 2007, 157,, 149-157,","journal-title":"Br J Dermatol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4172\/jbb.1000296","volume":"8","author":"Nayak P.","year":"2016","unstructured":"Nayak P. J Bioequivalence Bioavailab, Therapies available for the treatment of fungal nail infection.,, 2016, 8,, 208-210,","journal-title":"J Bioequivalence Bioavailab"},{"key":"ref=25","first-page":"2","volume":"9","author":"Leelavathi M.","year":"2014","unstructured":"Leelavathi M, Noorlaily MN. Malays Fam Physician, Onychomycosis nailed.,, 2014, 9,, 2-7,","journal-title":"Malays Fam Physician"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00128071-200304010-00005","volume":"4","author":"Darkes M.J.M.","year":"2003","unstructured":"Darkes MJM, Scott LJ, Goa KL. Am J Clin Dermatol, Terbinafine: a review of its use in onychomycosis in adults.,, 2003, 4,, 39-65,","journal-title":"Am J Clin Dermatol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/09546634.2011.579082","volume":"23","author":"Yin Z.","year":"2012","unstructured":"Yin Z, Xu J, Luo DAN. J Dermatolog Treat, A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole.,, 2012, 23,, 449-452,","journal-title":"J Dermatolog Treat"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1111\/j.1439-0507.2011.02038.x","volume":"54","author":"Graham L.V.D.","year":"2011","unstructured":"Graham LVD, Elewski BE. Mycoses, Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US.,, 2011, 54,, e679-e685,","journal-title":"Mycoses"},{"key":"ref=29","first-page":"198","volume":"55","author":"Trivedi N.A.","year":"2010","unstructured":"Trivedi NA, Shah PC. Int J Dermatol, A meta-analysis comparing efficacy of continuous terbinafine with intermittent itraconazole for toenail onychomycosis.,, 2010, 55,, 198-199,","journal-title":"Int J Dermatol"},{"key":"ref=30","first-page":"11","volume":"7","author":"Korting H.C.","year":"2009","unstructured":"Korting HC, Sch\u00f6llmann C. J Dtsch Dermatol Ges, The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes.,, 2009, 7,, 11-20,","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5114\/pdia.2014.40968","volume":"32","author":"Tabara K.","year":"2015","unstructured":"Tabara K, Szewczyk AE, Bienias W. Postepy Dermatol Alergol, Amorolfine vs. Ciclopirox - lacquers for the treatment of onychomycosis.,, 2015, 32,, 40-45,","journal-title":"Postepy Dermatol Alergol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000247612","volume":"184","author":"Reinel D.","year":"1992","unstructured":"Reinel D. Dermatology, Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use.,, 1992, 184,, 21-24,","journal-title":"Dermatology"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","volume":"43","author":"Gupta A.K.","year":"2000","unstructured":"Gupta AK, Fleckman P, Baran R. J Am Acad Dermatol, Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.,, 2000, 43,, S70-S80,","journal-title":"J Am Acad Dermatol"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1346-8138.2009.00773.x","volume":"37","author":"Shemer A.","year":"2010","unstructured":"Shemer A, Nathansohn N, Trau H, Amichai B, Grunwald MH. J Dermatol, Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.,, 2010, 37,, 137-139,","journal-title":"J Dermatol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000345105","volume":"226","author":"","year":"2013","unstructured":". Dermatology, Efficacy, safety and tolerability of an optimized avulsion technique with onyster\u00ae (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.,Lahfa M1, Bulai-Livideanu C, Baran R et al, 2013, 226,, 5-12,","journal-title":"Dermatology"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/2278-9596.146421","volume":"4","author":"Suthar H.P.","year":"2014","unstructured":"Suthar HP, Patel NM, Solanki AD, Barot JP. Arch Int Surg, Nail avulsion with adjuvant therapy in nail disorders.,, 2014, 4,, 158-161,","journal-title":"Arch Int Surg"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/0378-6323.95444","volume":"78","author":"Pandhi D.","year":"2012","unstructured":"Pandhi D, Verma P. Indian J Dermatol Venereol Leprol, Nail avulsion\u202f: indications and methods [surgical nail avulsion].,, 2012, 78,, 299-308,","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1473-2130.2004.00095.x","volume":"2","author":"Di Chiacchio N.","year":"2003","unstructured":"Di Chiacchio N, Kadunc BV, De Almeida AR, Madeira CL. J Cosmet Dermatol, Nail abrasion.,, 2003, 2,, 150-152,","journal-title":"J Cosmet Dermatol"},{"key":"ref=39","first-page":"461","volume":"55","author":"Angelo T.","year":"2017","unstructured":"Angelo T, Borgheti-cardoso N, Taveira F, Gratieri T, Gelfuso M. Med Mycol, Chemical and physical strategies in onychomycosis topical treatment\u202f: a review.,, 2017, 55,, 461-475,","journal-title":"Med Mycol"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3109\/03639045.2016.1165690","volume":"42","author":"Kushwaha A.","year":"2016","unstructured":"Kushwaha A, Shivakumar HN, Murthy SN. Drug Dev Ind Pharm, Iontophoresis for drug delivery into the nail apparatus: exploring hyponychium as the site of delivery.,, 2016, 42,, 1678-1682,","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3109\/03639045.2011.568946","volume":"37","author":"Nair A.B.","year":"2011","unstructured":"Nair AB, Kiran Vaka SR, Murthy SN. Drug Dev Ind Pharm, Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.,, 2011, 37,, 1253-1258,","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1517\/14656566.2012.681779","volume":"13","author":"Gupta A.K.","year":"2012","unstructured":"Gupta AK, Simpson FC. Expert Opin Pharmacother, New therapeutic options for onychomycosis.,, 2012, 13,, 1131-1142,","journal-title":"Expert Opin Pharmacother"},{"key":"ref=43","first-page":"370","volume":"8","author":"Surender V.","year":"2016","unstructured":"Surender V, Renu S. J Chem Pharm Res, Transungual drug delivery a pivotal remedy in onychomycosis.,, 2016, 8,, 370-381,","journal-title":"J Chem Pharm Res"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/jdv.12950","volume":"29","author":"Simmons B.J.","year":"2015","unstructured":"Simmons BJ, Griffith RD, Falto-Aizpurua LA, Nouri K. J Eur Acad Dermatol Venereol, An update on photodynamic therapies in the treatment of onychomycosis.,, 2015, 29,, 1275-1279,","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pdpdt.2016.07.010","volume":"15","author":"Bhatta A.K.","year":"2016","unstructured":"Bhatta AK, Keyal U, Wang XL. Photodiagn Photodyn Ther, Photodynamic therapy for onychomycosis: a systematic review.,, 2016, 15,, 228-235,","journal-title":"Photodiagn Photodyn Ther"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/jum.14526","volume":"37","author":"Kline-schoder A.","year":"2018","unstructured":"Kline-schoder A, Le Z, Zderic V. J Ultrasound Med, Ultrasound-enhanced drug delivery for treatment of onychomycosis.,, 2018, 37,, 1743-1752,","journal-title":"J Ultrasound Med"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.7863\/jum.2011.30.12.1723","volume":"30","author":"Abadi D.","year":"2011","unstructured":"Abadi D, Zderic V. J Ultrasound Med, Ultrasound-mediated nail drug delivery system.,, 2011, 30,, 1723-1730,","journal-title":"J Ultrasound Med"},{"key":"ref=48","first-page":"67","volume":"6","author":"Mathew F.","year":"2014","unstructured":"Mathew F, Bindumol KC, Paul J, Pathadan RP, Varghese V. Int J Pharm Pharm Sci, Understanding our natural nail - Antifungal agents.,, 2014, 6,, 67-73,","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/13543784.2016.1142529","volume":"25","author":"Gupta A.K.","year":"2016","unstructured":"Gupta AK, Studholme C. Expert Opin Investig Drugs, Novel investigational therapies for onychomycosis: an update.,, 2016, 25,, 297-305,","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2174\/157341312801784311","volume":"8","author":"Luiza RDA","year":"2012","unstructured":"Luiza RDA, Priscila KC. Curr Nanosci, Nanotechnology-based drug delivery systems for dermatomycosis treatment.,Kolenyak dF, et al, 2012, 8,, 512-519,","journal-title":"Curr Nanosci"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2017.03.019","volume":"523","author":"Soliman G.M.","year":"2017","unstructured":"Soliman GM. Int J Pharm, Nanoparticles as safe and effective delivery systems of antifungal agents\u202f: achievements and challenges.,, 2017, 523,, 15-32,","journal-title":"Int J Pharm"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11046-013-9622-7","volume":"175","author":"Flores F.C.","year":"2013","unstructured":"Flores FC, de Lima JA, Ribeiro RF. Mycopathologia, Antifungal activity of nanocapsule suspensions containing tea tree oil on the growth of trichophyton rubrum.,, 2013, 175,, 281-286,","journal-title":"Mycopathologia"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2017.11.008","volume":"535","author":"Flores F.C.","year":"2018","unstructured":"Flores FC, Sin W, Beck RCR, Cristiane B. Int J Pharm, Enhancement of tioconazole ungual delivery\u202f: combining nanocapsule formulation and nail poration approaches.,, 2018, 535,, 237-244,","journal-title":"Int J Pharm"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ijpharm.2017.06.052","volume":"528","author":"El-say K.M.","year":"2017","unstructured":"El-say KM, El-sawy HS. Int J Pharm, Polymeric nanoparticles\u202f: promising platform for drug delivery.,, 2017, 528,, 675-691,","journal-title":"Int J Pharm"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2015.10.026","volume":"220","author":"Chiu W.S.","year":"2015","unstructured":"Chiu WS, Belsey NA, Garrett NL. J Control Release, Drug delivery into microneedle-porated nails from nanoparticle reservoirs.,, 2015, 220,, 98-106,","journal-title":"J Control Release"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1021\/acsnano.8b02099","volume":"12","author":"Wang F.","year":"2018","unstructured":"Wang F, Yang P, Choi J. ACS Nano, Cross-linked fluorescent supramolecular nanoparticles for intradermal controlled release of antifungal drug: a therapeutic approach for onychomycosis.,, 2018, 12,, 6851-6859,","journal-title":"ACS Nano"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1208\/s12249-016-0488-0","volume":"17","author":"Mahtab A.","year":"2016 Dec","unstructured":"Mahtab A, Anwar M, Mallick N, Naz Z, Jain GK, Ahmad FJ. AAPS PharmSciTech, Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis.,, 2016 Dec, 17,, 1477-1490,","journal-title":"AAPS PharmSciTech"},{"key":"ref=58","first-page":"303","volume":"46","author":"Kumar S.","year":"2012","unstructured":"Kumar S, Talegaonkar S, Negi LM, Khan ZI. Ind J Pharm Edu Res, Design and development of ciclopirox topical nanoemulsion gel for the treatment of subungual onychomycosis.,, 2012, 46,, 303-311,","journal-title":"Ind J Pharm Edu Res"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2217\/nnm.15.49","volume":"10","author":"Bsieso E.A.","year":"2015","unstructured":"Bsieso EA, Nasr M, Moftah NH, Sammour OA, Abd El Gawad NA. Nanomedicine, Could nanovesicles containing a penetration enhancer clinically improve the therapeutic outcome in skin fungal diseases?,, 2015, 10,, 2017-2031,","journal-title":"Nanomedicine"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1208\/s12249-016-0528-9","volume":"18","author":"Elsherif N.I.","year":"2017","unstructured":"Elsherif NI, Shamma RN, Abdelbary G. AAPS PharmSciTech, Terbinafine hydrochloride trans-ungual delivery via nanovesicular systems: in vitro characterization and ex vivo evaluation.,, 2017, 18,, 551-562,","journal-title":"AAPS PharmSciTech"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ejps.2012.12.014","volume":"48","author":"Tanr\u0131verdi S.T.","year":"2013","unstructured":"Tanr\u0131verdi ST, \u00d6zer \u00d6. Eur J Pharm Sci, Novel topical formulations of terbinafine-hcl for treatment of onychomycosis.,, 2013, 48,, 628-636,","journal-title":"Eur J Pharm Sci"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/08982104.2015.1067892","volume":"26","author":"Ye D.","year":"2016","unstructured":"Ye D. J Liposome Res, Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis\u202f: in vitro and in vivo evaluation.,, 2016, 26,, 163-173,","journal-title":"J Liposome Res"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.biopha.2018.10.021","volume":"108","author":"Shukla T.","year":"2018","unstructured":"","journal-title":"Biomed Pharmacother"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1208\/s12249-011-9742-7","volume":"13","author":"Barot B.S.","year":"2012","unstructured":"Barot BS, Parejiya PB, Patel HK, Gohel MC, Shelat PK. AAPS PharmSciTech, Microemulsion-based gel of terbinafine for the treatment of onychomycosis\u202f: optimization of formulation using d-optimal design.,, 2012, 13,, 184-192,","journal-title":"AAPS PharmSciTech"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40005-015-0209-9","volume":"46","author":"Kansagra H.","year":"2016","unstructured":"Kansagra H, Mallick S. J Pharm Investig, Microemulsion-based antifungal gel of luliconazole for dermatophyte infections: formulation, characterization and efficacy studies.,, 2016, 46,, 21-28,","journal-title":"J Pharm Investig"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.01.057","volume":"355","author":"Tomme S.R. Van","year":"2008","unstructured":"Tomme SR Van, Storm G, Hennink WE. Int J Pharm, \n                        In situ gelling hydrogels for pharmaceutical and biomedical applications.,, 2008, 355,, 1-18,","journal-title":"Int J Pharm"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jddst.2017.10.018","volume":"43","author":"El-sherif N.I.","year":"2018","unstructured":"El-sherif NI, Shamma RN, Abdelbary G. J Drug Deliv Sci Technol, In-situ gels and nail lacquers as potential delivery systems for treatment of onychomycosis: a comparative study.,, 2018, 43,, 253-261,","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/03639045.2014.891129","volume":"41","author":"\u00c7elebi N.","year":"2015","unstructured":"\u00c7elebi N, Ermi\u015f S, \u00d6zkan S. Drug Dev Ind Pharm, Development of topical hydrogels of terbinafine hydrochloride and evaluation of their antifungal activity.,, 2015, 41,, 631-639,","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejpb.2012.11.004","volume":"83","author":"Nogueiras-nieto L.","year":"2013","unstructured":"Nogueiras-nieto L, Delgado-charro MB, Otero-espinar FJ. Eur J Pharm Biopharm, European journal of pharmaceutics and biopharmaceutics thermogelling hydrogels of cyclodextrin \/ poloxamer polypseudorotaxanes as aqueous-based nail lacquers\u202f: application to the delivery of triamcinolone acetonide and ciclopirox olamine.,, 2013, 83,, 370-377,","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=70","first-page":"AB102","volume":"68","author":"Iorizzo M.","year":"2013","unstructured":"Iorizzo M, Mailland F, Arraiz G, Frisenda L, Caserini M. J Am Acad Dermatol, An innovative terbinafine transungual solution [p-30]: dose finding investigation on clinical benefit in patients affected by mild-to-moderate toe onychomycosis.,, 2013, 68,, AB102-,","journal-title":"J Am Acad Dermatol"},{"key":"ref=71","author":"","unstructured":", .  , , Polichem SA. Study to evaluate the efficacy and\nsafety of p-3058 10% nail solution in the treatment of\ntoenail onychomycosis. Clini Trials Gov 2017;\nAvailable at:\n                    ,"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/13543784.2013.840289","volume":"23","author":"Gupta A.K.","year":"2014","unstructured":"Gupta AK, Simpson FC. Expert Opin Investig Drugs, Investigational drugs for onychomycosis.,, 2014, 23,, 97-106,","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1128\/JCM.00083-11","volume":"49","author":"Ghannoum M.","year":"2011","unstructured":"Ghannoum M, Isham N, Herbert J, Henry W, Yurdakul S. J Clin Microbiol, Activity of tdt 067 [terbinafine in transfersome] against agents of onychomycosis, as determined by minimum inhibitory and fungicidal concentrations.,, 2011, 49,, 1716-1720,","journal-title":"J Clin Microbiol"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1128\/AAC.00218-09","volume":"53","author":"Pannu J.","year":"2009","unstructured":"Pannu J, McCarthy A, Martin A. Antimicrob Agents Chemother, NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and candida albicans.,, 2009, 53,, 3273-3279,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=75","first-page":"4","volume":"17","author":"","year":"2012","unstructured":". Skin Therapy Lett, Simpson F. Device-based therapies for onychomycosis treatment.,Gupta a, 2012, 17,, 4-9,","journal-title":"Skin Therapy Lett"},{"key":"ref=76","first-page":"9","volume":"4","author":"Value S.J.R.I.","year":"2012","unstructured":"Value SJRI, Khanna S, Bajaj R, Khurana B, Srivastava K. Int J Drug Dev Res, Pharmacotherapeutic principles of ungual drug delivery system.,, 2012, 4,, 9-18,","journal-title":"Int J Drug Dev Res"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1208\/s12249-016-0488-0","volume":"17","author":"Mahtab A.","year":"2016","unstructured":"Mahtab A, Anwar M, Mallick N, Naz Z, Jain GK, Ahmad FJ. AAPS PharmSciTech, Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis.,, 2016, 17,, 1477-1490,","journal-title":"AAPS PharmSciTech"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1208\/s12249-017-0917-8","volume":"19","author":"Khattab A.","year":"2018","unstructured":"Khattab A, Shalaby S. AAPS PharmSciTech, Optimized ciclopirox-based eudragit rlpo nail lacquer: effect of endopeptidase enzyme as permeation enhancer on transungual drug delivery and efficiency against onychomycosis.,, 2018, 19,, 1048-1060,","journal-title":"AAPS PharmSciTech"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.xphs.2017.02.017","volume":"106","author":"Gregor\u00ed Valdes B.S.","year":"2017","unstructured":"Gregor\u00ed Valdes BS, Serro AP, Gordo PM. J Pharm Sci, New polyurethane nail lacquers for the delivery of terbinafine: formulation and antifungal activity evaluation.,, 2017, 106,, 1570-1577,","journal-title":"J Pharm Sci"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2016.12.055","volume":"518","author":"Laffleur F.","year":"2017","unstructured":"Laffleur F, Ataii M. Int J Pharm, Preparation and evaluation of a novel dosage form for onychomycosis.,, 2017, 518,, 105-110,","journal-title":"Int J Pharm"}],"container-title":["Pharmaceutical Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T05:53:42Z","timestamp":1565675622000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170296\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2211738507666190228104031","relation":{},"ISSN":["2211-7385"],"issn-type":[{"value":"2211-7385","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}